Clinical Trials Sponsored by Danielle Kim Turgeon

Total 5 results

Danielle Kim Turgeon

Terminated

Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer

Cholangiocarcinoma

United States
Danielle Kim Turgeon

Terminated

Study of QRH-882260 Heptapeptide Application in the Colon

Colon Cancer Prevention

United States
Danielle Kim Turgeon
Olympus Corporation

Completed

Study of KCC Peptide Application in the Colon (KCC 1B)

Colorectal Cancer | Inflammatory Bowel Disease (IBD) | Colon Polyps

United States
Danielle Kim Turgeon
PvP Biologics, Inc.

Terminated

Gastric Gluten-Degradation Activity of PvP001

Digestive System Disease

United States
D. Kim Turgeon, MD
University of Washington

Completed

Fluorescence QRH-882260 Peptide Imaging in the Bile Duct

Cholangiocarcinoma

United States

3

Subscribe